Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives.
Since our founding in 1909, our ever-growing mastery of plasma, diagnostics and life sciences, backed by our ethical leadership and industry-leading quality and safety standards, have contributed to a healthier and more sustainable society.
Grifols included in TIME Magazine’s ‘World’s Best Companies’ list for second year in a row
13 September, 2024
Grifols has been included in TIME Magazine’s ”World’s Best Companies” 2024 ranking, making the company a member of the list in each of the two years the publication has produced it.
TIME, in collaboration with the data firm Statista, has identified the 1,000 top-performing companies across the globe based on three key criteria: employee satisfaction, revenue growth and sustainability (ESG). Grifols has ascended rapidly in the last year, leaping from 675th place to 282nd.
This steep climb reflects the company’s commitment to enhancing employee satisfaction, driving revenue growth and advancing sustainability efforts.
Latest news
GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339
Grifols Accelerates Performance in Q2 and Reaffirms Full Year Guidance
Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients
Scientific innovation at work
Our deep and expanding knowledge of plasma and the life sciences is helping us better understand human health and research potential treatments to improve it.
Commitment to people and the planet
Aligned with the United Nations plan to achieve the Sustainable Development Goals defined in its 2030 Agenda, we work every day to do more and do better to contribute to the health and quality of life of people around the world.
The patients we serve are able to lead better lives. Patients inspire the work we do every day.
Lifegiving plasma
Our innovative medicines made from human plasma enable millions of patients with chronic and rare diseases to lead more fulfilling lives.
Get to know us
Our history
We trace our roots back to 1909 when Dr. Josep Antoni Grifols i Roig founded a clinical analysis laboratory in Barcelona, the precursor to Laboratorios Grifols.
Company
Grifols' mission, to improve people's health and well-being, has patients, donors and society at the heart of everything we do.
Careers
Would you like to make a positive impact on the lives of others? Join our team!